Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRC
3476
DELISTED
MRC Global
MRC
| $1.86M | ﹤0.01% |
185,181
-1,033,845
| -85% | -$9.78M |
|
3477
Medallion Financial
MFIN
$274M
| $1.86M | ﹤0.01% |
235,618
+113,444
| +93% | +$778K |
|
3478
NovoCure
NVCR
$2.08B
| $1.86M | ﹤0.01% |
44,816
+28,265
| +171% | +$1.76M |
|
3479
CALL
Lufax Holding
LU
$1.14B
| $1.86M | ﹤0.01% |
325,000
| – | – |
|
|
OPI
3480
DELISTED
Office Properties Income Trust
OPI
| $1.86M | ﹤0.01% |
241,387
+213,678
| +771% | +$1.62M |
|
3481
Green Brick Partners
GRBK
$3.15B
| $1.86M | ﹤0.01% |
+32,723
| New | +$1.52M |
|
3482
Atomera
ATOM
$164M
| $1.86M | ﹤0.01% |
211,654
+119,454
| +130% | +$942K |
|
|
NREF
3483
NexPoint Real Estate Finance
NREF
$325M
| $1.85M | ﹤0.01% |
118,958
-19,662
| -14% | -$281K |
|
|
JOYY
3484
JOYY Inc
JOYY
$3.65B
| $1.85M | ﹤0.01% |
60,380
+643
| +1% | +$18.8K |
|
3485
Maximus
MMS
$3.13B
| $1.85M | ﹤0.01% |
21,929
+8,231
| +60% | +$677K |
|
|
SAVE
3486
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.85M | ﹤0.01% |
107,900
-50,000
| -32% | -$819K |
|
|
FTCH
3487
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $1.85M | ﹤0.01% |
305,900
-8,600
| -3% | -$41.4K |
|
3488
Vericel Corp
VCEL
$2.1B
| $1.85M | ﹤0.01% |
49,142
-55,913
| -53% | -$1.84M |
|
3489
PUT
Dropbox
DBX
$7.76B
| $1.85M | ﹤0.01% |
+69,200
| New | +$1.58M |
|
3490
Helios Technologies
HLIO
$2.41B
| $1.84M | ﹤0.01% |
+27,912
| New | +$1.65M |
|
3491
PUT
M&T Bank
MTB
$34.3B
| $1.84M | ﹤0.01% |
14,900
-37,900
| -72% | -$4.59M |
|
3492
CALL
State Street SPDR S&P Bank ETF
KBE
$1.69B
| $1.84M | ﹤0.01% |
51,200
| – | – |
|
3493
CALL
Medifast
MED
$136M
| $1.84M | ﹤0.01% |
20,000
+10,000
| +100% | +$890K |
|
3494
Ormat Technologies
ORA
$6.34B
| $1.84M | ﹤0.01% |
22,906
-72,979
| -76% | -$6.18M |
|
3495
Structure Therapeutics
GPCR
$3.38B
| $1.84M | ﹤0.01% |
44,226
+8,767
| +25% | +$246K |
|
|
B
3496
DELISTED
Barnes Group Inc.
B
| $1.84M | ﹤0.01% |
43,549
-5,372
| -11% | -$219K |
|
3497
Akebia Therapeutics
AKBA
$243M
| $1.84M | ﹤0.01% |
2,005,958
+1,095,000
| +120% | +$1.06M |
|
3498
Cricut
CRCT
$1.21B
| $1.83M | ﹤0.01% |
150,211
+79,362
| +112% | +$868K |
|
3499
Cannae Holdings
CNNE
$678M
| $1.83M | ﹤0.01% |
90,656
+26,557
| +41% | +$510K |
|
3500
CALL
Revvity
RVTY
$14.4B
| $1.83M | ﹤0.01% |
+15,400
| New | +$1.89M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.